The Agency shall ensure that:
the electronic data and document exchange mechanism follows, to the extent that optimal operability of the Union product database does not adversely impact other Union systems, current recognised international standards for the identification of medicinal products and exchange of medicinal product information or relevant subsets thereof;
the structure of data is consistent between the Union product database and other Union systems using the same reference data;
the Union product database functions as the Union master data repository where information about veterinary medicinal products is registered;
the Union product database provides a functionality to enable other systems to interoperate with it;
the Union product database consumes reference data from other existing databases or IT tools to avoid duplication of data input at Union level and ensure data quality;
the Union product database is able to consume structured data provided in the course of the regulatory process, as relevant;
the Union product database provides the necessary data to the Union pharmacovigilance database;
the Union product database is linked to the Union database of manufacturing, import and wholesale distribution;
the Union product database has a service-oriented Application Programming Interface (‘API’) for the exchange of data and documents with the systems used by marketing authorisation holders, competent authorities, the Agency and the Commission.